Indian BioPharma Leaders Conclave

Pharma, a well-established industry in India, combined with rising personal incomes and government healthcare outlays, is predicted to lead to annual average growth of around 16-17 per cent in the near future. Efforts to improve medical infrastructure, rising health pandemics, growing health insurance penetration and investments in research & development are amongst factors that will result in this growth.

Traditionally, the Indian pharmaceutical industry has focused primarily on generics as a business model, enjoying a leading position in the global generic pharmaceutical space, accounting for over 20% of global exports and nearly 80% of market share.